US2020347019A1PendingUtilityA1
Quinoline-based proteasome inhibitors and uses thereof
Est. expiryMar 31, 2037(~10.7 yrs left)· nominal 20-yr term from priority
A61P 35/00A61K 31/47C07D 215/06
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein are quinoline compounds useful for, among other things, inhibition of the proteasome and for treatment of cancer and inflammation.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A compound of the formula II:
wherein:
R 6 is hydrogen, alkyl or aryl;
R 7 is hydrogen, alkyl, alkenyl, cycloalkyl, aryl, cycloheteroalkyl or alkoxy;
R 8 is hydrogen, halogen, or alkyl;
R 9 is hydrogen, halogen, hydroxy, alkyl, alkoxy, aminoalkyl or heterocyclyl; and
R 10 is hydrogen, halogen, lower alkyl, or lower alkoxy.Join the waitlist — get patent alerts
Track US2020347019A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.